These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9883926)

  • 21. Hemolytic disease of the neonate secondary to anti-Fya.
    Weinstein L; Taylor ES
    Am J Obstet Gynecol; 1975 Mar; 121(5):643-5. PubMed ID: 1115167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.
    Sonneveld ME; Koelewijn J; de Haas M; Admiraal J; Plomp R; Koeleman CA; Hipgrave Ederveen AL; Ligthart P; Wuhrer M; van der Schoot CE; Vidarsson G
    Br J Haematol; 2017 Feb; 176(4):651-660. PubMed ID: 27891581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemolytic disease of the newborn caused by anti-c, anti-E and anti-Fya antibodies: report of five cases.
    Babinszki A; Berkowitz RL
    Prenat Diagn; 1999 Jun; 19(6):533-6. PubMed ID: 10416968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A young woman with a transfusion-related pregnancy complication.
    Gustavsen A; Njerve IU; Sitras V; Haugen G; Tølløfsrud PA; Akkök ÇA
    Tidsskr Nor Laegeforen; 2020 Jan; 140(1):. PubMed ID: 31948214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemolytic disease of the newborn from anti-E. A case report.
    Strohm PL; Iams JD; Kennedy MS
    J Reprod Med; 1988 Apr; 33(4):404-6. PubMed ID: 3130484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin G subclasses and isoimmunized pregnancy outcome.
    Taslimi MM; Sibai BM; Mason JM; Dacus JV
    Am J Obstet Gynecol; 1986 Jun; 154(6):1327-32. PubMed ID: 3717242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical consequences of the extremely rare anti-PP1Pk isoantibodies in pregnancy: a case series and review of the literature.
    Di Ciaccio P; Cutts B; Alahakoon TI; Dennington PM; Soo LA; Curnow J
    Vox Sang; 2021 May; 116(5):591-600. PubMed ID: 33326620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serological conflict: relation between antibody titer, Liley's zone and the condition of the fetus and newborn infant].
    Czeszyńska M; Zieliński M; Czajkowski Z; Hnatyszyn G
    Acta Haematol Pol; 1991; 22(2):279-89. PubMed ID: 1841500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of red cells preserved in extended storage media for exchange transfusion in anti-k haemolytic disease of the newborn.
    Win N; Amess P; Needs M; Hewitt PE
    Transfus Med; 2005 Apr; 15(2):157-60. PubMed ID: 15859984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of anti-c in haemolytic disease of the newborn.
    Kozlowski CL; Lee D; Shwe KH; Love EM
    Transfus Med; 1995 Mar; 5(1):37-42. PubMed ID: 7767396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.
    Verduin EP; Brand A; van de Watering LM; Claas FH; Oepkes D; Lopriore E; Doxiadis II; Schonewille H
    Br J Haematol; 2015 Feb; 168(3):443-51. PubMed ID: 25244566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-"D" rhesus and irregular antibodies--an approach to management.
    Dornan KJ
    Ir Med J; 1982 Mar; 75(3):79-82. PubMed ID: 6804410
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients.
    Fernández-Jiménez MC; Jiménez-Marco MT; Hernández D; González A; Omeñaca F; de la Cámara C
    Vox Sang; 2001 Feb; 80(2):117-20. PubMed ID: 11348543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive plasmapheresis as a therapeutic measure in Rhesus-immunised women.
    Clarke CA; Elson CJ; Bradley J; Donohoe WT; Lehane D; Hughes-Jones NC
    Lancet; 1970 Apr; 1(7651):793-8. PubMed ID: 4191432
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemolytic disease of the newborn due to anti-U.
    Novaretti MC; Jens E; Pagliarini T; Bonif cio Sle O; Dorlhiac-Llacer PE; Chamone Dd Dde A
    Rev Hosp Clin Fac Med Sao Paulo; 2003; 58(6):320-3. PubMed ID: 14762491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of haemolytic disease of the newborn due to a new red cell antigen, Zd.
    Svanda M; Procházka R; Kout M; Giles CM
    Vox Sang; 1970 Apr; 18(4):366-9. PubMed ID: 5426507
    [No Abstract]   [Full Text] [Related]  

  • 38. A case of unexplained mild Rh (D) haemolytic disease in utero.
    Bromilow IM; Downing I; Walkinshaw SA; Welch CR; Duguid JK
    Transfus Med; 1995 Mar; 5(1):31-5. PubMed ID: 7767395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amniotic fluid anti-D and the maternal serum: liquor ratio in rhesus haemolytic disease of the newborn.
    Neil VS; Bowell PJ
    Clin Lab Haematol; 1984; 6(1):39-43. PubMed ID: 6734098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemolytic disease of the fetus and newborn.
    de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
    Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.